Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

95.00
Delayed Data
As of Jun 23
 -1.78 / -1.84%
Today’s Change
11.57
Today|||52-Week Range
96.92
+113.87%
Year-to-Date
Top-Ranked Health Care ETFs to Buy Now
Jun 23 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Healthcare ETF (IYH) Hits New 52-Week High
Jun 23 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content
Clovis Up Nearly 50% on Solid Data from Ovarian Cancer Study
Jun 20 / Zacks.com - Paid Partner Content
Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3%
Jun 22 / Zacks.com - Paid Partner Content
Biotech Movers: AveXis, Clovis, Epizyme
Jun 20 / TheStreet.com - Paid Partner Content
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
Jun 21 / Zacks.com - Paid Partner Content
Here's Why Clovis Oncology (CLVS) Stock Skyrocketed Today
Jun 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close96.78
Today’s open96.50
Day’s range92.33 - 96.70
Volume2,536,243
Average volume (3 months)1,972,831
Market cap$4.6B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+44.04%
Earnings growth (next 5 years)+31.86%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.95+2.09%
CTLTCatalent Inc-0.58-1.53%
TAROTaro Pharmaceutical ...+2.04+1.79%
AGNPRAAllergan plc-2.56-0.29%
Data as of 4:05pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts